Understanding Bladder Cancer Risk: Mendelian Randomization Analysis of Immune Cell and Inflammatory Factor Influence

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2024 Oct 25

PMID 39450166

Authors

Hiocheng Un

Wumier Wusimanjiang

Wenhao Zhan

Xinxin Zhang

Minghao Li

Jiahao Lei

Renxuan Lin

YuLiang Zhang

Junxing Chen

Zongren Wang

Affiliations

Soon will be listed here.

Abstract

Introduction: The intricate roles of immune cells and inflammatory factors in cancer, particularly their association with the risk of bladder cancer, are not well understood.

Methods: This study aimed to clarify potential causal relationships between these elements and the development of bladder cancer using genome-wide association study (GWAS) summary statistics for 731 immune cell phenotypes and 91 circulating inflammatory factors (cases=2,053; controls=287,137). The primary analytical approach was Inverse Variance Weighting (IVW), supplemented by MR-Egger regression, weighted median, and weighted mode analyses. Sensitivity analyses included Cochran Q test, MR-Egger intercept test, and Leave-one-out test.

Results: The findings indicated that monocytes are positively correlated with an increased risk of bladder cancer. On the contrary, double-negative (DN) T cells, HLA DR+CD8br, and CD28 on CD28+CD45RA+CD8br T cells exhibited an inverse correlation, suggesting a possible protective effect. Furthermore, inflammatory factors IL-20, IL-22RA1, and Eotaxin were significantly associated with an increased risk of bladder cancer.

Discussion: These results suggest that certain immune cell phenotypes and inflammatory factors may play a role in the development of bladder cancer and could serve as potential biomarkers for assessing tumor risk. The findings also offer new insights into the pathogenesis of bladder cancer, indicating a need for further investigation.

References

Burgess S, Butterworth A, Thompson S . Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013; 37(7):658-65. PMC: 4377079. DOI: 10.1002/gepi.21758. View

Bowden J, Davey Smith G, Haycock P, Burgess S . Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator. Genet Epidemiol. 2016; 40(4):304-14. PMC: 4849733. DOI: 10.1002/gepi.21965. View

Lee S, Lee E, Kim S, Jeong P, Cho Y, Yun S . Identification of pro-inflammatory cytokines associated with muscle invasive bladder cancer; the roles of IL-5, IL-20, and IL-28A. PLoS One. 2012; 7(9):e40267. PMC: 3433484. DOI: 10.1371/journal.pone.0040267. View

Witjes J, Bruins H, Carrion A, Cathomas R, Comperat E, Efstathiou J . European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines. Eur Urol. 2023; 85(1):17-31. DOI: 10.1016/j.eururo.2023.08.016. View

Hartwig F, Davey Smith G, Bowden J . Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption. Int J Epidemiol. 2017; 46(6):1985-1998. PMC: 5837715. DOI: 10.1093/ije/dyx102. View

Chiu Y, Wei C, Lin Y, Hsu Y, Chang M . IL-20 and IL-20R1 antibodies protect against liver fibrosis. Hepatology. 2014; 60(3):1003-14. DOI: 10.1002/hep.27189. View

Orru V, Steri M, Sidore C, Marongiu M, Serra V, Olla S . Complex genetic signatures in immune cells underlie autoimmunity and inform therapy. Nat Genet. 2020; 52(10):1036-1045. PMC: 8517961. DOI: 10.1038/s41588-020-0684-4. View

Verbanck M, Chen C, Neale B, Do R . Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018; 50(5):693-698. PMC: 6083837. DOI: 10.1038/s41588-018-0099-7. View

Ma Y, Adjemian S, Mattarollo S, Yamazaki T, Aymeric L, Yang H . Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells. Immunity. 2013; 38(4):729-41. DOI: 10.1016/j.immuni.2013.03.003. View

10.

Rutz S, Wang X, Ouyang W . The IL-20 subfamily of cytokines--from host defence to tissue homeostasis. Nat Rev Immunol. 2014; 14(12):783-95. DOI: 10.1038/nri3766. View

11.

Voronov E, Shouval D, Krelin Y, Cagnano E, Benharroch D, Iwakura Y . IL-1 is required for tumor invasiveness and angiogenesis. Proc Natl Acad Sci U S A. 2003; 100(5):2645-50. PMC: 151394. DOI: 10.1073/pnas.0437939100. View

12.

Zheng J, Baird D, Borges M, Bowden J, Hemani G, Haycock P . Recent Developments in Mendelian Randomization Studies. Curr Epidemiol Rep. 2017; 4(4):330-345. PMC: 5711966. DOI: 10.1007/s40471-017-0128-6. View

13.

Nitschke K, Worst T, von Rhade S, Thaqi B, Neuberger M, Wessels F . High IL-22RA1 gene expression is associated with poor outcome in muscle invasive bladder cancer. Urol Oncol. 2021; 39(8):499.e1-499.e8. DOI: 10.1016/j.urolonc.2021.05.010. View

14.

Ridker P, MacFadyen J, Thuren T, Everett B, Libby P, Glynn R . Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial. Lancet. 2017; 390(10105):1833-1842. DOI: 10.1016/S0140-6736(17)32247-X. View

15.

Davey Smith G, Ebrahim S . Data dredging, bias, or confounding. BMJ. 2002; 325(7378):1437-8. PMC: 1124898. DOI: 10.1136/bmj.325.7378.1437. View

16.

Schalck A, Sakellariou-Thompson D, Forget M, Sei E, Hughes T, Reuben A . Single-Cell Sequencing Reveals Trajectory of Tumor-Infiltrating Lymphocyte States in Pancreatic Cancer. Cancer Discov. 2022; 12(10):2330-2349. PMC: 9547957. DOI: 10.1158/2159-8290.CD-21-1248. View

17.

Zheng Z, Mao S, Zhang W, Liu J, Li C, Wang R . Dysregulation of the Immune Microenvironment Contributes to Malignant Progression and Has Prognostic Value in Bladder Cancer. Front Oncol. 2021; 10:542492. PMC: 7773013. DOI: 10.3389/fonc.2020.542492. View

18.

Zhao J, Stacey D, Eriksson N, Macdonald-Dunlop E, Hedman A, Kalnapenkis A . Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets. Nat Immunol. 2023; 24(9):1540-1551. PMC: 10457199. DOI: 10.1038/s41590-023-01588-w. View

19.

Burgess S, Thompson S . Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol. 2017; 32(5):377-389. PMC: 5506233. DOI: 10.1007/s10654-017-0255-x. View

20.

Skrivankova V, Richmond R, Woolf B, Davies N, Swanson S, VanderWeele T . Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): explanation and elaboration. BMJ. 2021; 375:n2233. PMC: 8546498. DOI: 10.1136/bmj.n2233. View